Oxford Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-62,166
| Closed | -$438K | – | 1034 |
|
|
2019
Q4 | $438K | Sell |
62,166
-110,540
| -64% | -$779K | 0.01% | 1293 |
|
|
2019
Q3 | $2.07M | Sell |
172,706
-43,050
| -20% | -$517K | 0.05% | 514 |
|
|
2019
Q2 | $2.61M | Buy |
215,756
+73,811
| +52% | +$894K | 0.06% | 518 |
|
|
2019
Q1 | $1.78M | Buy |
141,945
+1,231
| +0.9% | +$15.5K | 0.04% | 635 |
|
|
2018
Q4 | $947K | Sell |
140,714
-46,939
| -25% | -$316K | 0.02% | 891 |
|
|
2018
Q3 | $1.9M | Buy |
187,653
+23,986
| +15% | +$243K | 0.04% | 690 |
|
|
2018
Q2 | $1.12M | Sell |
163,667
-1,939
| -1% | -$13.2K | 0.02% | 975 |
|
|
2018
Q1 | $1.42M | Buy |
165,606
+132,304
| +397% | +$1.14M | 0.03% | 759 |
|
|
2017
Q4 | $680K | Buy |
+33,302
| New | +$680K | 0.01% | 1087 |
|